
BMS Has a Promising Cancer Drug. Now It Has to Get Out of Its Own Way.
It’s been a good week for Bristol Myers Squibb, and it deserves to enjoy it. On October 12, the company said an experimental radiation drug called RYZ101 slowed the growth …
BMS Has a Promising Cancer Drug. Now It Has to Get Out of Its Own Way. Read More






